Vaccine Manufacturing Hub Will Help UK Meet Coronavirus Challenge
Will Work With Oxford And AstraZeneca On Fast-Tracked Candidate
Vaccine manufacturing capacity has been lost in the UK in recent decades. Now a new Vaccines Manufacturing Innovation Centre will re-seed that capacity and expertise - and the pandemic is accelerating its arrival.
You may also be interested in...
UK As New Global Base, Serum Institute Mulls Acquisition Or Greenfield Unit
After setting up a sales base in the UK, Serum Institute could consider an acquisition in Europe or investment in an Oxford facility as it ties up production for its multiple COVID-19 vaccines. Is Wockhardt’s Wrexham facility an option?
UK Bags More COVID-19 Vaccines And Backs J&J, Novavax Trials
With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.
Coronavirus Update: AZ Gets $1bn From US, Secures Capacity For One Billion Vaccine Doses
Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.